Composition for Suppressing Norovirus Infection
AssigneeMorinaga Milk Industry Co., Ltd.
InventorsHirotsugu Oda, Hiroyuki Wakabayashi, Tetsuya Matsumoto
Life of this patent
Estimating the term…
Abstract
An object of this present invention is to provide a composition for inhibiting norovirus infection which can inhibit norovirus from infecting a human, and the object is achieved by a composition for inhibiting norovirus infection containing one or more kinds of bacteria selected from the group consisting of Bifidobacterium breve, Bifidobacterium longum subsp. infantis, Bifidobacterium animalis, Bifidobacterium bifidum, Bifidobacterium catenulatum, Lactobacillus gasseri, Lactobacillus helveticus, Lactobacillus delbrueckii subsp. Bulgaricus and Lactobacillus paracasei as an active ingredient.
Claims25
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method manufacturing a composition that is able to inhibit norovirus infection, comprising a step of formulating a bacterium selected from the group consisting of Bifidobacterium breve, Bifidobacterium longum subsp. infantis, Bifidobacterium animalis, Bifidobacterium bifidum, Bifidobacterium catenulatum, Lactobacillus gasseri, Lactobacillus helveticus, Lactobacillus delbrueckii subsp. bulgaricus and Lactobacillus paracasei, and combinations thereof into a composition in the manufacture of a composition for inhibiting norovirus infection.
(canceled)
(canceled)
(canceled)
A method for inhibiting norovirus from infecting a human, including comprising a step of administering to the human one or more kinds of bacteria a bacterium selected from the group consisting of Bifidobacterium breve, Bifidobacterium longum subsp. infantis, Bifidobacterium animalis, Bifidobacterium bifidum, Bifidobacterium catenulatum, Lactobacillus gasseri, Lactobacillus helveticus, Lactobacillus delbrueckii subsp. bulgaricus and Lactobacillus paracasei, and combinations thereof to a human.
A method for preventing or a method for treating a syndrome or a symptom which can be prevented or treated by inhibiting norovirus infection, including comprising a step of administering to a human one or more kinds of bacteria a bacterium selected from the group consisting of Bifidobacterium breve, Bifidobacterium longum subsp. infantis, Bifidobacterium animalis, Bifidobacterium bifidum, Bifidobacterium catenulatum, Lactobacillus gasseri, Lactobacillus helveticus, Lactobacillus delbrueckii subsp. bulgaricus and Lactobacillus paracasei and combinations thereof to a human.
Dependencies are inferred from the claim text.